Sure, keep saying that Melky Cabrera cashed in on his PED use

58 Comments

My friend Josh Fisher alerted me to something in Buster Olney’s column over the weekend about the fallout from Melky Cabrera’s positive PED test last year:

Before Melky Cabrera was suspended this past summer, the Giants were engaged in conversations with Cabrera about a deal that would’ve paid the outfielder something in the range of $75 million of $85 million …

He added in an update yesterday that the Giants said a deal wasn’t necessarily close, but there was no denial of the discussions either.

I offer this only as a reminder to those people who like to point to Cabrera’s $16 million deal as some sort of affront and/or proof that taking PEDs pays. To the contrary, Melky’s positive PED test cost him as much as $69 million dollars. SIXTY-NINE MILLION DOLLARS. Plus the salary he lost during his suspension.

I presume we are going to have stiffer PED penalties in the near future. And that the rash of positive tests for testosterone and the like last season are significant reasons for that. But to suggest that there are not deterrents against drug use in place already is ridiculous. It’s just that some people — most notably Melky Cabrera — are too clueless to be deterred.

Twins will not pick up Glen Perkins’ 2018 option

Stephen Dunn/Getty Images
Leave a comment

The Twins have informed reliever Glen Perkins they will not pick up his 2018 club option worth $6.5 million, MLB.com’s Rhett Bollinger reports. Instead, he will be paid $700,000 per his buyout clause.

Perkins, 34, has pitched a total of 7 2/3 innings over the last two seasons due to shoulder and biceps injuries. Bollinger adds that the two could come to terms on a minor league deal, but if they can’t reach an agreement, the lefty is likely to retire.

From 2011-15, Perkins emerged as one of the better relievers in baseball, making three All-Star teams. He compiled an aggregate 2.84 ERA with 340 strikeouts and 73 walks across 313 1/3 innings.